EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Targets For Cancer Chemotherapy Transcription Factors And Other Nuclear Proteins 2002th Edition Nicholas B La Thangue

Name: Targets For Cancer Chemotherapy Transcription Factors And Other Nuclear Proteins 2002th Edition Nicholas B La Thangue
SKU: BELL-4588258
Price: 31.00 USD
Availability: InStock
Rating: 5 (40 reviews)

SKU: BELL-4588258

$ 31.00 ~~$ 45.00~~ (-31%)

5.0

40 reviews

Targets For Cancer Chemotherapy Transcription Factors And Other Nuclear Proteins 2002th Edition Nicholas B La Thangue instant download after payment.

Publisher: Humana Press

File Extension: PDF

File size: 5.14 MB

Pages: 352

Author: Nicholas B. La Thangue, Lasantha R. Bandara

ISBN: 9780896039384, 0896039382

Language: English

Year: 2002

Edition: 2002

Product desciption

Targets For Cancer Chemotherapy Transcription Factors And Other Nuclear Proteins 2002th Edition Nicholas B La Thangue by Nicholas B. La Thangue, Lasantha R. Bandara 9780896039384, 0896039382 instant download after payment.

In Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins, a panel of leading basic researchers, pharmaceutical scientists, and clinical oncologists explain in detail the therapeutically-relevant protein targets that contribute to cancer pathology and spell out their implications for cancer drug discovery and clinical application. The authors identify and illuminate selected transcription factor oncoproteins and tumor suppressors, together with nuclear proteins that are central to the phenotype of the tumor cell involved in chromatin control. The emphasis is on new targets and approaches to cancer treatment derived from the cancer cell cycle, gene control targets, and angiogenesis.